EU approves Moderna’s COVID-19 vaccine
Vaccine is also currently being reviewed in the UK - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/eu_approves_modernas_covid-19_vaccine_1360881Vaccine is also currently being reviewed in the UK - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/eu_approves_modernas_covid-19_vaccine_1360881Funding for effective, 'less risky' treatments extended until summer 2021 - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/nhs_extends_covid-friendly_at-home_cancer_care_1366141WHO's SAGE panel backs wide use of jab in adults, including in people aged over 65 - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/who_panel_recommends_azoxfords_covid-19_vaccine_1363139Study is investigating company's lead asset SFX-01 - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/evgen_recruits_over_100_patients_into_covid-19_trial_1363515Gov has alleged that the company breached its obligations under the agreement - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/uk_terminates_valneva_covid-19_vaccine_supply_agreement_1377317Entry closes on 22nd October – so don’t miss out on your chance to enter now - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/entry_still_open_for_2021_marketer_of_the_year,_sales_and_communications_awards!_1380857Funding will be given to four long COVID research studies - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/uk_government_pledges_18.5m_for_long_covid_research_1363628In the RECOVERY trial, tocilizumab treatment significantly reduced deaths caused by COVID-19 - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/nhs_to_roll-out_tocilizumab_treatment_for_covid-19_1363221The entry deadline for the 2021 Marketer of the Year, Sales and Communications Awards has been extended to 22nd of October - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/entry_deadline_extended_for_the_2021_marketer_of_the_year,_sales_and_communications_awards!_1376473CureVac’s CVnCoV is currently being investigated in a randomised, placebo-controlled Phase IIb/III clinical trial - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/curevacs_covid-19_vaccine_begins_rolling_review_with_ema_1363316